No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
RGLS Regulus Therapeutics
- 2.2200
- -0.1200-5.13%
Close Apr 18 16:00 ET
145.33MMarket Cap-1405P/E (TTM)
2.3750High2.1800Low202.90KVolume2.3500Open2.3400Pre Close460.00KTurnover0.49%Turnover RatioLossP/E (Static)65.47MShares3.790052wk High6.85P/B92.24MFloat Cap1.080052wk Low--Dividend TTM41.55MShs Float3071.9974Historical High--Div YieldTTM8.33%Amplitude0.7600Historical Low2.2670Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Regulus Files to Sell 62.5M Shares of Common Stock for Holders
Buy Rating Reaffirmed for Regulus Therapeutics Amid Promising Drug Development Milestones
Regulus Therapeutics Inc (RGLS) Reports Year-End Earnings, Highlights Key Clinical Advancements
Regulus Therapeutics: Oversubscribed $100M Private Placement to Extend Cash Runway Into 1H of 2026 >RGLS
Regulus Therapeutics: Oversubscribed $100M Private Placement to Extend Cash Runway Into 1H of 2026 >RGLS
Express News | Regulus Therapeutics Q4 EPS $(0.40) Misses $(0.39) Estimate
Regulus Therapeutics 4Q Loss $8.06M >RGLS
Regulus Therapeutics 4Q Loss $8.06M >RGLS
Comments
$Regulus Therapeutics(RGLS.US$
Good premium - Buy and trade sell put options to earn option premium...weekly
Good premium - Buy and trade sell put options to earn option premium...weekly
San Diego-based Therapeutics Company Announces $100M Private Placement
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity.
The biopharmaceutical industry is a rapidly evolving space, with companies constantly seeking funds to fuel their innovative efforts. One such company making headlines is Regulus Therapeutics Inc. (NASDAQ: RGLS). The San Diego-based company recently announced an oversubscribed private placement of equity, raising a remarkable $100 million. $Regulus Therapeutics(RGLS.US$
...
The biopharmaceutical industry is a rapidly evolving space, with companies constantly seeking funds to fuel their innovative efforts. One such company making headlines is Regulus Therapeutics Inc. (NASDAQ: RGLS). The San Diego-based company recently announced an oversubscribed private placement of equity, raising a remarkable $100 million. $Regulus Therapeutics(RGLS.US$
...
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Be a voice no echo : MLGO
TrytosaveabitOP Be a voice no echo: Going to be a fight there to get back to PM high! But GL